CYP2C19Your two copies: *1/*2
Intermediate metabolizer
One copy works and one doesn't.
Handles several SSRIs, acid reducers such as omeprazole, and the blood thinner clopidogrel.
This result doesn't change the label.
Example report. Made from Leslie Knope's DNA data so you can see what yours will look like. Get your own report
Female sexual healthExample report
Flibanserin
Addyi
Use as directed
Your CYP2C19 result means somewhat lower CYP2C19 activity than usual, but the FDA gives no genetic dosing change for flibanserin at this result.
The genes behind this label
The guidelines read one gene for flibanserin. Each card shows the two copies this person inherited and what they mean.
What the guidelines say
What each guideline says about your result.
CYP2C19Intermediate metabolizer
- In plain words
- Your CYP2C19 result means somewhat lower CYP2C19 activity than usual, but the FDA gives no genetic dosing change for flibanserin at this result.
- What it means
- No FDA guidance for your genotype
- What the label suggests
- Initiate therapy with recommended starting dose.
About flibanserin
Flibanserin (Addyi) is a once-nightly tablet for acquired, generalized hypoactive sexual desire disorder (HSDD) in women under 65.
- Used for
- Acquired, generalized hypoactive sexual desire disorder in women under 65
Don't change a dose on your own. Bring this report to your prescriber or pharmacist. They can weigh it with everything else they know about you.